Update: 01.10.2024
Last week: 38 week 2024 (16.09.2024 - 22.09.2024)
Last full month: August 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 882 | 3.9% | 13.2% | -0.1 | 16 104 020 | 2.4% | 9.0% | -0.3 | 5.0% |
| MoM | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| YTD | 281 855 | 22.2% | 11.8% | 3 | 589 962 895 | 37.0% | 9.4% | 2 | -8.8% |
| MAT | 392 039 | 25.4% | 11.2% | 2.4 | 816 192 836 | 41.1% | 9.1% | 1.7 | -1.9% |
| BRAINMAX | |||||||||
| WoW | 1 687 | 6.4% | 100.0% | 0 | 5 916 286 | 5.3% | 100.0% | 0 | 6.4% |
| MoM | 6 855 | 12.4% | 100.0% | 0 | 24 503 753 | 13.7% | 100.0% | 0 | 12.4% |
| YTD | 47 288 | 59.2% | 100.0% | 0 | 167 023 858 | 65.1% | 100.0% | 0 | 59.2% |
| MAT | 64 240 | 69.7% | 100.0% | 0 | 226 887 557 | 78.4% | 100.0% | 0 | 69.7% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 391 | 2.1% | 46.0% | 0.8 | 44 464 792 | 2.3% | 37.5% | 0.2 | 0.3% |
| MoM | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| YTD | 627 319 | -5.0% | 45.0% | 0.5 | 1 972 332 645 | -2.7% | 36.9% | -2.8 | -6.1% |
| MAT | 835 751 | -0.3% | 45.3% | 0.6 | 2 637 342 904 | 3.9% | 37.5% | -2.2 | -1.6% |
| MIGRENIUM | |||||||||
| WoW | 9 820 | 1.7% | 0.4% | 0 | 3 302 581 | 1.4% | 0.6% | 0 | -0.8% |
| MoM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| YTD | 439 966 | -9.7% | 0.5% | -0.1 | 137 772 867 | 54.2% | 0.7% | 0.2 | 6.8% |
| MAT | 594 322 | -9.8% | 0.5% | -0.1 | 171 113 585 | 41.9% | 0.6% | 0.1 | 10.5% |
| MODELAX-N | |||||||||
| WoW | 25 569 | 2.0% | 20.6% | 0 | 12 148 553 | 2.7% | 13.6% | 0 | 1.9% |
| MoM | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| YTD | 1 084 342 | 31.0% | 22.5% | 3.7 | 472 840 569 | 80.5% | 14.5% | 4.1 | 9.2% |
| MAT | 1 424 718 | 44.3% | 21.3% | 4.4 | 593 708 325 | 87.9% | 13.4% | 3.8 | 14.5% |
| REDUXIN | |||||||||
| WoW | 10 121 | 0.3% | 32.4% | 0 | 52 508 456 | 3.4% | 44.3% | 0.7 | 0.3% |
| MoM | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| YTD | 457 586 | -7.8% | 32.9% | -0.6 | 2 436 408 433 | 12.5% | 45.5% | 3.1 | -6.1% |
| MAT | 599 223 | -4.8% | 32.5% | -1.1 | 3 143 202 894 | 16.3% | 44.7% | 2.4 | -1.6% |
| REDUXIN FORTE | |||||||||
| WoW | 3 194 | -0.7% | 10.2% | -0.1 | 13 265 979 | -3.2% | 11.2% | -0.6 | 0.3% |
| MoM | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| YTD | 125 315 | 0.9% | 9.0% | 0.6 | 540 460 230 | 12.8% | 10.1% | 0.7 | -6.1% |
| MAT | 167 165 | 7.7% | 9.1% | 0.8 | 714 952 700 | 19.5% | 10.2% | 0.8 | -1.6% |
| SALVISAR | |||||||||
| WoW | 11 274 | -0.9% | 1.5% | 0 | 4 820 960 | -0.7% | 1.3% | 0 | 1.5% |
| MoM | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
| YTD | 380 831 | 4.0% | 1.4% | 0.1 | 156 244 760 | 30.0% | 1.2% | 0.1 | -2.0% |
| MAT | 513 041 | -7.2% | 1.3% | -0.1 | 199 844 633 | 7.9% | 1.1% | -0.1 | 2.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 281 855 | 22.2% | 11.8% | 3 | 589 962 895 | 37.0% | 9.4% | 2 | -8.8% |
| BRAINMAX | 47 288 | 59.2% | 100.0% | 0 | 167 023 858 | 65.1% | 100.0% | 0 | 59.2% |
| GOLDLINE PLUS | 627 319 | -5.0% | 45.0% | 0.5 | 1 972 332 645 | -2.7% | 36.9% | -2.8 | -6.1% |
| MIGRENIUM | 439 966 | -9.7% | 0.5% | -0.1 | 137 772 867 | 54.2% | 0.7% | 0.2 | 6.8% |
| MODELAX-N | 1 084 342 | 31.0% | 22.5% | 3.7 | 472 840 569 | 80.5% | 14.5% | 4.1 | 9.2% |
| REDUXIN CAPS | 457 586 | -7.8% | 32.9% | -0.6 | 2 436 408 433 | 12.5% | 45.5% | 3.1 | -6.1% |
| REDUXIN FORTE | 125 315 | 0.9% | 9.0% | 0.6 | 540 460 230 | 12.8% | 10.1% | 0.7 | -6.1% |
| SALVISAR | 380 831 | 4.0% | 1.4% | 0.1 | 156 244 760 | 30.0% | 1.2% | 0.1 | -2.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 392 039 | 25.4% | 11.2% | 2.4 | 816 192 836 | 41.1% | 9.1% | 1.7 | -1.9% |
| BRAINMAX | 64 240 | 69.7% | 100.0% | 0 | 226 887 557 | 78.4% | 100.0% | 0 | 69.7% |
| GOLDLINE PLUS | 835 751 | -0.3% | 45.3% | 0.6 | 2 637 342 904 | 3.9% | 37.5% | -2.2 | -1.6% |
| MIGRENIUM | 594 322 | -9.8% | 0.5% | -0.1 | 171 113 585 | 41.9% | 0.6% | 0.1 | 10.5% |
| MODELAX-N | 1 424 718 | 44.3% | 21.3% | 4.4 | 593 708 325 | 87.9% | 13.4% | 3.8 | 14.5% |
| REDUXIN CAPS | 599 223 | -4.8% | 32.5% | -1.1 | 3 143 202 894 | 16.3% | 44.7% | 2.4 | -1.6% |
| REDUXIN FORTE | 167 165 | 7.7% | 9.1% | 0.8 | 714 952 700 | 19.5% | 10.2% | 0.8 | -1.6% |
| SALVISAR | 513 041 | -7.2% | 1.3% | -0.1 | 199 844 633 | 7.9% | 1.1% | -0.1 | 2.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 882 | 3.9% | 13.2% | -0.1 | 16 104 020 | 2.4% | 9.0% | -0.3 | 5.0% |
| BRAINMAX | 1 687 | 6.4% | 100.0% | 0 | 5 916 286 | 5.3% | 100.0% | 0 | 6.4% |
| GOLDLINE PLUS | 14 391 | 2.1% | 46.0% | 0.8 | 44 464 792 | 2.3% | 37.5% | 0.2 | 0.3% |
| MIGRENIUM | 9 820 | 1.7% | 0.4% | 0 | 3 302 581 | 1.4% | 0.6% | 0 | -0.8% |
| MODELAX-N | 25 569 | 2.0% | 20.6% | 0 | 12 148 553 | 2.7% | 13.6% | 0 | 1.9% |
| REDUXIN CAPS | 10 121 | 0.3% | 32.4% | 0 | 52 508 456 | 3.4% | 44.3% | 0.7 | 0.3% |
| REDUXIN FORTE | 3 194 | -0.7% | 10.2% | -0.1 | 13 265 979 | -3.2% | 11.2% | -0.6 | 0.3% |
| SALVISAR | 11 274 | -0.9% | 1.5% | 0 | 4 820 960 | -0.7% | 1.3% | 0 | 1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| BRAINMAX | 6 855 | 12.4% | 100.0% | 0 | 24 503 753 | 13.7% | 100.0% | 0 | 12.4% |
| GOLDLINE PLUS | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| MIGRENIUM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| MODELAX-N | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| REDUXIN CAPS | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| REDUXIN FORTE | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| SALVISAR | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs